- December 2, 2005
- Significant Decision Gives Patients Better Access to LipoScience's Heart Disease Test
- November 29, 2005
- CeNeRx BioPharma Announces $18.5 Million Series A Financing
- October 24, 2005
- After Change Up Top, Syntonix Inks Boehringer Ingelheim Deal Worth Up to $63M
- October 21, 2005
- Syntonix and Boehringer Ingelheim Enter Collaboration for Up to $63 Million to Optimize Therapeutic Peptide Candidates for Inhalation
- October 18, 2005
- BrainCells, Inc. Appoints James A. Schoeneck Chief Executive Officer
- October 17, 2005
- Dynogen Initiates Phase II Trial of Ddp225 for Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome
- September 12, 2005
- A Better Way to Ambush Aids? Panacos Pharmaceutical's experimental drug opens the door to a new line of attack (Business Week)
- August 3, 2005
- LabCorp to Offer LipoScience's NMR LipoProfile Test
- July 28, 2005
- TargeGen, Inc. Selects Lead Drug for Clinical Development As A Topical (Eyedrop) Treatment For Wet Macular Degeneration and Other Eye Diseases
- July 15, 2005
- BrainCells Gets $8M In First Part Of Committed $17.7M Series A
- May 12, 2005
- Spherics Secures $26.4M Financing to Advance Clinical Programs Based on Proprietary Oral Drug Delivery Platform
- May 4, 2005
- Bayhill Therapeutics raises $35.4 million in Series B financing
- March 31, 2005
- Serono and Syntonix Sign Worldwide Agreement to Develop and Commercialize an Inhaleable Interferon-Beta Therapy for Multiple Sclerosis
- March 11, 2005
- Vitex Closes Merger with Panacos Pharmaceuticals
$20 Million Financing Also Closed and Funded - January 10, 2005
- A. M. Pappas & Associates Names Charles Hsu as Venture Partner and Geoffrey Barker as Executive-in-Residence